SYMPOSIA

Poster Presentations
[PP-064] Ref. No: 272
Escitalopram induced galacthorrea: Phenomenon presentation
Aslı Aktümen Bilgin 1 , Birmay Çam 2
1 Zonguldak Atatürk Devlet Hastanesi Psikiyatri Kliniği, Zonguldak, Turkey
2 Gönen Devlet Hastanesi Psikiyatri Kliniği Balıkesir, Turkey
E-mail: draslibilgin@gmail.com
Hyperprolactinemia can present with many physical symptoms such as galactorrhea, amenorrhea, infertility and osteoporosis and
can also cause psychological problems like depression and anxiety. Hyperprolactinemia is mostly seen as a side effect of antipsychotic
medications and rarely can also occur as a side effect of an SSRI. Hyperprolactinemia and galactorrhea as adverse effects of escitalopram
are rarely encountered. In this text we present a case, who developed hyperprolactinemia and galactorrhea on the sixth day of treatment.
The prolactin level decreased to normal after stopping the medication.
Key words: Escitalopram, galactorrhea, hyperprolactinemia
Bulletin of Clinical Psychopharmacology 2011;21(Suppl. 2):S160
[PP-065] Ref. No: 276
Amisulpride use in treatment of Tourette’s disorder
Yasemen Taner, Hande Ayraler Taner
Departmant of Child and Adolescent Psychiatry, Gazi University, Ankara, Turkey
E-mail: taneryasemen@yahoo.com
Tourette’s disorder is a neuropsychiatric disease characterised by chronic vocal and motor tics that leads to severe psychosocial disability.
Many old and new generation antipsyshotics had been used in the treatment of Tourette’s Disorder, especially antipsychotics which have
strong effects on D2 receptors. Amisulpride is an antipsychotic which has strong effects on D2 and D3 receptors. Parkinsonism, endocrine
system side effects, and weight gain are less frequent than with the other antipsychotics. Amisulpride is safely used in the treatment of
schizophrenia and the other psychoses in adults. In this case report we discuss amisulpride use in 3 cases with Tourette’s disorder. These
cases previously used other antipsychotics for Tourette’s disorder treatment. Amisulpride was used at a dose of 75-200 mg/day. After
treatment in all three of these cases, the Yale Global Tic Severity Scale score decreased.
Key words: Tourette’s disorder, amisulpride
Bulletin of Clinical Psychopharmacology 2011;21(Suppl. 2):S160
[PP-066] Ref. No: 299
Lithium associated glossodynia syndrome: A case report
Hasan Toğul
Gata Haydarpasa Training Hospital, İstanbul, Turkey
E-mail: hasan_togul@hotmail.com
Lithium revolutionized the treatment of bipolar disorder and continues to be the most widely used treatment for this disorder. There
are several side effects that result from lithium carbonate therapy and among the most commonly reported are polydipsia, polyuria,
tremor and weight gain. There have also been reports of various skin lesions with lithium treatment. The following case report suggests
that mucosal lesions may possibly result from lithium therapy. Glossodynia is commonly seen in old female patients. In our case, a 45
year old male had glossodynia after lithium carbonate therapy. The patient’s symptoms were under control with a lithium regimen for a
year. He stopped using lithium in January 2011 and one and a half months later he was hospitilazed because of dysphoric mania. After
his hospitalization, lithium therapy was started again. Three weeks later he reported mucosal ulcerations in the mouth, with associated
soreness of the tongue. The tongue appeared inflamed, with cracks or irregular reddish areas. He was evaluated by a dermatologist, who
diagnosed him with glossodynia. No other medical causes for the lesions were found; the lesions were presumed to be secondary to
S160 Bulletin of Clinical Psychopharmacology, Vol: 21, Supplement: 2, 2011 - www.psikofarmakoloji.org